Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar 17;1(1):10.
doi: 10.1186/2043-9113-1-10.

Roles of XB130, a novel adaptor protein, in cancer

Affiliations

Roles of XB130, a novel adaptor protein, in cancer

Atsushi Shiozaki et al. J Clin Bioinforma. .

Abstract

Adaptor proteins, with multi-modular structures, can participate in the regulation of various cellular functions. During molecular cloning process of actin filament associated protein, we have discovered a novel adaptor protein, referred to as XB130. The human xb130 gene is localized on chromosome 10q25.3, and encodes an 818 amino acid protein. The N-terminal region of XB130 includes several tyrosine phosphorylation sites and a proline-rich sequence that might interact with Src homology 2 and 3 domain-containing proteins, respectively. Our studies have indeed implicated XB130 as a likely substrate and regulator of tyrosine kinase-mediated signaling. Down-regulation of endogenous XB130 with small interfering RNA reduced c-Src activity, IL-8 production and phosphorylation of Akt in human lung epithelial cells. Further, XB130 binds the p85α subunit of phosphatidyl-inositol-3-kinase and subsequently mediates signaling through RET/PTC in thyroid cancer cells. Knockdown of XB130 using small interfering RNA inhibited G1-S phase progression, induced spontaneous apoptosis and enhanced intrinsic and extrinsic apoptotic stimulus-induced cell death in human lung and thyroid cancer cells. Growth of tumors in nude mice formed from XB130 short hairpin RNA stably transfected human thyroid cancer cells were significantly reduced, with decreased cell proliferation and increased apoptosis. Further, XB130 has a high affinity to lamellipodial F-actin meshwork and is involved in the motility and invasiveness of cancer cells. Gene expression profiling identified 246 genes significantly changed in XB130 short hairpin RNA transfected thyroid cancer cells. Among them, 57 genes are related to cell proliferation or survival, including many transcription regulators. Pathway analysis showed that the top ranked disease related to XB130 is Cancer, and the top molecular and cellular functions are Cellular Growth and Proliferation, and Cell Cycle. These observations suggest that the expression of XB130 may affect cell proliferation, survival, motility and invasion in various cancer cells. A deeper understanding of these mechanisms may lead to the discovery of XB130 as an important mediator in tumor development and as a novel therapeutic target for cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of the XB130 and AFAP protein structures. The N-terminal region of XB130 includes several tyrosine phosphorylation sites and a proline-rich sequence that may interact with Src homology (SH) 2 and SH3 domain-containing proteins. The middle portion harbors two pleckstrin homology (PH) domains, while the C-terminal region contains a coiled-coil domain. A common feature of XB130 (818aa) and AFAP (730aa) is the presence of potential SH2, SH3-binding sites and two PH domains. A coiled-coil domain of XB130 shares partial similarity with the leucine zipper domain and in AFAP.
Figure 2
Figure 2
Roles of XB130 in cell cycle and survival of cancer. XB130 specifically binds p85α subunit of PI3K, which subsequently activate Akt. Akt plays an essential role in cell proliferation and survival.
Figure 3
Figure 3
Roles of XB130 in cancer behavior. XB130 interacts with binding partners and regulates cell cycle, survival, migration and invasion of cancer through tyrosine kinase-mediated signaling.

References

    1. Flynn DC. Adaptor proteins. Oncogene. 2001;20:6270–6272. doi: 10.1038/sj.onc.1204769. - DOI - PubMed
    1. Csiszar A. Structural and functional diversity of adaptor proteins involved in tyrosine kinase signalling. Bioessays. 2006;28:465–479. doi: 10.1002/bies.20411. - DOI - PubMed
    1. Pawson T. Regulation and targets of receptor tyrosine kinases. Eur J Cancer. 2002;38(Suppl 5):S3–S10. doi: 10.1016/S0959-8049(02)80597-4. - DOI - PubMed
    1. Schlessinger J. New roles for Src kinases in control of cell survival and angiogenesis. Cell. 2000;100:293–296. doi: 10.1016/S0092-8674(00)80664-9. - DOI - PubMed
    1. Tsygankov AY. Non-receptor protein tyrosine kinases. Front Biosci. 2003;8:s595–635. doi: 10.2741/1106. - DOI - PubMed

LinkOut - more resources